US2006223824A1PendingUtilityA1

Serotonergic agents

Assignee: WYETH CORPPriority: Nov 28, 2000Filed: Jan 11, 2006Published: Oct 5, 2006
Est. expiryNov 28, 2020(expired)· nominal 20-yr term from priority
A61P 43/00A61P 5/00A61P 9/00A61P 25/24A61P 3/04A61P 25/06A61P 25/22A61P 25/08A61P 25/28A61P 25/14A61P 25/18A61P 25/36A61P 25/02A61P 25/34A61P 25/32A61P 25/20A61P 25/16A61P 1/14A61P 13/10A61P 15/00A61K 31/496
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel piperazine derivatives are provided having the formula wherein R 1 is cyano, nitro, trifluoromethyl or halogen, or pharmaceutically acceptable acid addition salts thereof, which are useful as 5-HT 1A receptor antagonists.

Claims

exact text as granted — not AI-modified
1 - 5 . (canceled)  
     
     
         6 . A method for treating sexual dysfunction in a patient in need thereof, the method comprising providing to the patient a therapeutically effective amount of a compound of formula (III):  
       
         
           
           
               
               
           
         
       
       wherein R 1  is cyano, nitro, trifluoromethyl or halogen, or pharmaceutically acceptable acid addition salts thereof.  
     
     
         7 - 12 . (canceled)  
     
     
         13 . The method of  claim 6 , wherein the compound is (R)-4-cyano-N-{2-[4-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine-1-yl]-propyl}-N-pyridin-2-yl-benzamide.

Join the waitlist — get patent alerts

Track US2006223824A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.